Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
GSK Utvikling AS
AS
Active
Org 925732346
Rørgata 8, 6517
Kristiansund N
Buying and selling of own real estate
·
NACE 6811
Est. 2020 · 5 years old
0 employees
Monitor
Share
Norway
/
Companies
/
Buying and selling of own real estate
/
GSK Utvikling AS
Overview
Financials
People & ownership
Related companies
Loading company…
People & ownership
Management
Actively employed in the business
Name
Role
Member since
Former (1)
HO
Hans Olav Søbstad
Chief Executive Officer
Chief Executive Officer
2020 – 2022
Board of directors
Non-executive oversight
Name
Role
Member since
Current (4)
JE
Joar Eide
Chairman
Chairman
2025
ØG
Øyvind Gjøen
Board of Directors
Board of Directors
2025
PG
Per Gunnar Vidhammer
Board of Directors
Board of Directors
2022
PA
Per Arne Fladseth
Board of Directors
Board of Directors
2025
Former (2)
HO
Hans Olav Søbstad
Board of Directors
Board of Directors
2020 – 2022
PE
Pål Erik Forsnes
Board of Directors
Board of Directors
2022 – 2025
Shareholders
As of last annual report
Smiå As — 25%
Rebos As — 25%
Ksu Eiendom As — 25%
75%
Shareholder
Type
Ownership
Votes
Since
Smiå As
Company
25%
25%
2025
Rebos As
Company
25%
25%
2025
Ksu Eiendom As
Company
25%
25%
2025
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
More on GSK Utvikling AS
Overview →
Headline figures, risk assessment and company summary
Financials & key figures →
Revenue, EBITDA, balance sheet and 5-year trend
Related companies →
Corporate hierarchy, parent and subsidiary network